Undertreatment or Overtreatment With Statins: Where Are We?

Statins, in addition to healthy lifestyle interventions, are the cornerstone of lipid-lowering therapy. Other low-density lipoprotein (LDL)-lowering drugs include ezetimibe, bile acid sequestrants, and PCSK9 inhibitors. As new evidence emerges from new clinical trials, therapeutic goals change, lead...

Descripción completa

Detalles Bibliográficos
Autores principales: García-Fernández-Bravo, Irene, Torres-Do-Rego, Ana, López-Farré, Antonio, Galeano-Valle, Francisco, Demelo-Rodriguez, Pablo, Alvarez-Sala-Walther, Luis A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9105719/
https://www.ncbi.nlm.nih.gov/pubmed/35571155
http://dx.doi.org/10.3389/fcvm.2022.808712

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9105719/
https://www.ncbi.nlm.nih.gov/pubmed/35571155
http://dx.doi.org/10.3389/fcvm.2022.808712

Ejemplares similares